An Exploratory Study of Ganglioside GM1 in Acute Ischemic Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 300 participants.

Also called NCT04952064

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 300 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04952064
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04952064. Randomized; single masking; primary purpose treatment. Start 2021-07-28 (actual); primary completion 2022-07-18 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
An Exploratory Study of Ganglioside GM1 in Acute Ischemic Stroke
Condition
Stroke, Ischemic
Intervention (Drug)
Monosialoganglioside GM1
Lead sponsor
General Hospital of Shenyang Military Region (class: other)
Collaborator
The Third Xiangya Hospital of Central South University (class: other)

Record details

Record id
cardio:ct-nct04952064
Content hash
0aba4b7fb834835d9754ceb963373b879ac4513bed3a7df4382d2d7b19a71c3e